General MedicationsORALGeneric
REVIA
NALTREXONE HYDROCHLORIDE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: 901 REQUIRED Marketing status: Discontinued
Summary
Approval overview REVIA is listed in Drugs@FDA under application 018932 (NDA).
Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient NALTREXONE HYDROCHLORIDE Form and strength TABLET;ORAL - 50MG Sponsor TEVA WOMENS Submission history Latest submission status date: 2013-10-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview REVIA is listed in Drugs@FDA under application 018932 (NDA). Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient NALTREXONE HYDROCHLORIDE Form and strength TABLET;ORAL - 50MG Sponsor TEVA WOMENS Submission history Latest submission status date: 2013-10-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: 901 REQUIRED
Interaction Notes
- No interaction notes stored yet.